Reirradiation with Alternating Docetaxel-Based Chemotherapy for Recurrent Head and Neck Squamous Cell Carcinoma

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Strahlentherapie und Onkologie (Print)

• Publication date

  2010-04-26

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1007/s00066-010-2082-9PMID 20437016
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes.

  2009influential reference
• Docetaxel in the management of patients with head and neck squamous cell carcinoma

  2008cited by this paper
• Recent advances in head and neck cancer.

  2008cited by this paper
• Platinum-based chemotherapy plus cetuximab in head and neck cancer.

  2008cited by this paper
• Helical Tomotherapy

  2008cited by this paper
• Three-Dimensional Conformal or Stereotactic Reirradiation of Recurrent, Metastatic or New Primary Tumors

  2008cited by this paper
• Longitudinal Assessment of Parotid Function in Patients Receiving Tomotherapy for Head-and-Neck Cancer

  2008cited by this paper
• Evaluation of prognostic factors and two radiation techniques in patients treated with surgery followed by radio(chemo)therapy or definitive radio(chemo)therapy for locally advanced head-and-neck cancer

  2008cited by this paper
• Reirradiation in squamous cell head and neck cancer: recent developments and future directions

  2007cited by this paper
• Intensity-modulated radiotherapy with concurrent chemotherapy for previously irradiated, recurrent head and neck cancer.

  2007influential reference
• Reirradiation for Recurrent Neck Metastases of Head-and-Neck Tumors Using CT-Guided Interstitial 192Ir HDR Brachytherapy

  2007cited by this paper
• Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911.

  2007influential reference
• The chemoradiation paradigm in head and neck cancer

  2007cited by this paper
• Salvage re-irradiation for recurrent head and neck cancer.

  2007influential reference
• Curative Brachytherapy for Recurrent/Residual Tongue Cancer

  2007cited by this paper
• Locally recurrent, previously irradiated head and neck cancer: concurrent re-irradiation and chemotherapy, or chemotherapy alone?

  2006cited by this paper
• Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma.

  2006influential reference
• Reirradiation alternating with docetaxel and cisplatin in inoperable recurrence of head-and-neck cancer: a prospective phase I/II trial.

  2005influential reference
• Phase I Study of Concomitant Chemoradiotherapy with Irinotecan, 5‐FU., and Hydroxyurea for Patients with Advanced and/or Recurrent Head and Neck Cancer

  2005cited by this paper
• A review on re-irradiation for recurrent and second primary head and neck cancer.

  2005cited by this paper
• Twice-daily reirradiation for recurrent and second primary head-and-neck cancer with gemcitabine, paclitaxel, and 5-fluorouracil chemotherapy.

  2005cited by this paper
• RTOG 96-10: reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck.

  2001influential reference
• RTOG 9610: phase I study of reirradiation (RRT) with concurrent hydroxyurea (HU) and 5-fluorouracil (FU) in patients (PTS) with squamous cell cancer of the head and neck (SCH&N)

  2000cited by this paper
• New guidelines to evaluate the response to treatment in solid tumors

  2000cited by this paper
• New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.

  2000cited by this paper
• Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients.

  1998cited by this paper
• Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck.

  1996cited by this paper
• Rationale for different chemotherapeutic and radiation therapy strategies in cancer management

  1991cited by this paper
• Hydroxyurea, fluorouracil, and concomitant radiotherapy in poor-prognosis head and neck cancer: a phase I-II study.

  1989cited by this paper

• Safety of Boron Neutron Capture Therapy with Borofalan(10B) and Its Efficacy on Recurrent Head and Neck Cancer: Real-World Outcomes from Nationwide Post-Marketing Surveillance

  2024cites this paper
• In Regard to Hirose and Sato.

  2024cites this paper
• Clinical Results and Prognostic Factors in BNCT for Recurrent Squamous Cell Carcinoma of the Head and Neck under the Japan National Health Insurance System: A Retrospective Study of the Initial 47 Patients.

  2024cites this paper
• Advancements of radiotherapy for recurrent head and neck cancer in modern era

  2023cites this paper
• Systemic therapy‐based split‐course stereotactic body radiation therapy

  2022cites this paper
• Retreatment of Recurrent or Second Primary Head and Neck Cancer After Prior Radiation: Executive Summary of the American Radium Society® (ARS) Appropriate Use Criteria (AUC): Expert Panel on Radiation Oncology - Head and Neck Cancer.

  2022cites this paper
• Concurrent chemoradiotherapy with cisplatin and docetaxel for head and neck squamous cell carcinoma

  2021cites this paper
• Boron neutron capture therapy using cyclotron-based epithermal neutron source and borofalan(10B) for recurrent or locally advanced head and neck cancer (JHN002): An open-label phase II trial.

  2020cites this paper
• Re-irradiation for head and neck squamous cell carcinoma.

  2017cites this paper
• Re-Irradiation: New Frontiers

  2017cites this paper
• Reirradiation of head and neck cancer: Long‐term disease control and toxicity

  2017cites this paper
• Dendritic cells as therapeutic targets in neuroinflammation

  2016cites this paper
• A Retrospective Study of Reirradiation for Patients with Locoregional Recurrent Head and Neck Cancer: A Single-Institution Experience

  2016cites this paper
• Necroptosis-independent signaling by the RIP kinases in inflammation

  2016cites this paper
• SWI/SNF-directed stem cell lineage specification: dynamic composition regulates specific stages of skeletal myogenesis

  2016cites this paper
• The interplay between regulated necrosis and bacterial infection

  2016cites this paper
• Nucleoside modifications in the regulation of gene expression: focus on tRNA

  2016cites this paper
• Outcomes of patients with loco-regionally recurrent or new primary squamous cell carcinomas of the head and neck treated with curative intent reirradiation at Mayo Clinic

  2016cites this paper
• Polyglutamine androgen receptor-mediated neuromuscular disease

  2016cites this paper
• Re-irradiation in Head and Neck Cancer

  2016cites this paper
• Functional and pathological relevance of HERC family proteins: a decade later

  2016cites this paper
• Cellular response to DNA interstrand crosslinks: the Fanconi anemia pathway

  2016cites this paper
• Isoalantolactone Enhances the Radiosensitivity of UMSCC-10A Cells via Specific Inhibition of Erk1/2 Phosphorylation

  2015cites this paper
• Is there a place for brachytherapy in the salvage treatment of cervical lymph node metastases of head and neck cancers?

  2015cites this paper
• Salvage radiotherapy in patients with local recurrent esophageal cancer after radical radiochemotherapy

  2015cites this paper
• A retrospective study of head and neck re-irradiation for patients with recurrent or second primary head and neck cancer: the McGill University experience

  2015cites this paper
• Radiotherapy for Oral Cavity Cancer

  2015cites this paper
• Recurrent and second primary squamous cell carcinoma of the head and neck: When and how to reirradiate

  2015cites this paper
• Results of chemoselection with short induction chemotherapy followed by chemoradiation or surgery in the treatment of functionally inoperable carcinomas of the pharynx and larynx.

  2013cites this paper
• Salvage radiotherapy in patients with recurrent esophageal carcinoma

  2012cites this paper
• Reirradiation with cetuximab in locoregional recurrent and inoperable squamous cell carcinoma of the head and neck: feasibility and first efficacy results.

  2012cites this paper
• Re-irradiation combined with capecitabine in locally recurrent squamous cell carcinoma of the head and neck

  2012cites this paper
• High-dose-rate and pulsed-dose-rate brachytherapy in palliative treatment of head and neck cancers.

  2012cites this paper
• Prospective study on the dose distribution to the acoustic structures during postoperative 3D conformal radiotherapy for parotid tumors

  2011cites this paper
• Evaluation of Time, Attendance of Medical Staff, and Resources During Radiotherapy for Head and Neck Cancer Patients

  2011cites this paper
• Effectiveness of postoperative radiotherapy in patients with small oral and oropharyngeal squamous cell carcinoma and concomitant ipsilateral singular cervical lymph node metastasis (pN1)

  2011cites this paper
• Radiosensitization of head and neck cancer cells by the phytochemical agent sulforaphane

  2011cites this paper
• Combined-modality treatment in advanced oral squamous cell carcinoma

  2011cites this paper
• Incidence of dermatitis in head and neck cancer patients treated with primary radiotherapy and cetuximab

  2011cites this paper
• Evaluation of time, attendance of medical staff, and resources during radiotherapy for breast cancer patients

  2011cites this paper
• Cystatin C – A Fast and Reliable Biomarker for Glomerular Filtration Rate in Head and Neck Cancer Patients

  2011cites this paper
• Réirradiation des carcinomes de la tête et du cou

  2010cites this paper
• Outcome after Re-Irradiation of Head and Neck Cancer Patients

  2010cites this paper
• Feasibility, Toxicity, and Efficacy of Short Induction Chemotherapy of Docetaxel Plus Cisplatin or Carboplatin (TP) Followed by Concurrent Chemoradio ­ therapy for Organ Preservation in Advanced Cancer of the Hypopharynx, Larynx, and Base of Tongue

  2010cites this paper
• [Reirradiation of head and neck cancers].

  2010cites this paper
• Head and Neck Cancer

  2010cites this paper